References
- Amris C. J., Larsen V., Mogensen B., Storm O. Infusion of porcine plasmin in man. Scand. J. clin. Lab. Invest. 1963; 15: 179
- Astrup T., Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem. 1952; 40: 346
- Astrup T., Ollendorff P. Estimation of thromboplastin activation in plasma. Scand. J. clin. Lab. Invest. 1961; 13: 377
- Fletcher A. P., Alkjærsig N., Sherry S. The maintenance of a sustained thrombolytic state in man. J. clin. Invest. 1959; 38: 1096
- Fletcher A. P. The in vivo genesis of the coagulation defect complicating pathologic plasma proteolytic (“fibrinolytic”) states: Study of an iatrogenically induced lesion. J. Lab. clin. Med. 1961; 58: 816
- McFarlane A. S. Efficient trace labelling of protein with iodine. Nature 1958; 182: 53
- Müllertz S. Mechanism of activation and effect of plasmin in blood. Acta physiol. scand. 1956; 38, Suppl. 130
- Ollendorff P. Improvements in the thrombin generation test. Thrombos. Diathes. hemorrh. (Stuttg.) IV. 1960; 244
- Ouchi H., Warren R. Detection of intravascular thrombi by means of I131-labelled plasmin. Surgery 1962; 51: 42
- Storm O., Larsen V., Mogensen B. Experimental thrombolysis in dogs with a highly purified plasmin. Thrombos. Diathes. hemorrh. (Stuttg.) Suppl. 1 1962; VI: 288
- Storm O. Plasmin therapy combined with anticoagulants in severe thromboembolic conditions. Acta chir. scand. Suppl. 1961; 283: 315